On this week's podcast, Ferdous Al-Faruque discusses next-generation sequencing developments and progress by one company in the liquid biopsy space, while Elizabeth Orr previews an upcoming FDA patient-preference workshop and talks about a guidance document from the US agency on adaptive clinical trials. Please listen to our podcast.
